Related Experiment Video

Updated: May 22, 2026

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications

Juan A Ramos1, Fernando J Bianco

  • 1Universidad de Carabobo, School of Health Sciences, Bárbula, Venezuela.

Indian Journal of Urology : IJU : Journal of the Urological Society of India
|May 5, 2012
PubMed

Insights

Cannabinoids show promise for prostate cancer treatment by reducing cancer cell viability and androgen receptor expression. Further clinical studies are recommended for metastatic prostate cancer patients, leveraging cannabinoid analgesic properties.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Prostate cancer is a significant global health issue and a leading cause of cancer-related death in American men.
  • Prostate tissue contains cannabinoid receptors, and their activation has demonstrated anti-androgenic effects.

Purpose of the Study:

  • To review current findings on the role of cannabinoid receptors in prostate cancer.
  • To explore the potential therapeutic applications of cannabinoids in prostate cancer management.

Main Methods:

  • A PubMed search was conducted using terms like "cannabis," "cannabinoids," "prostate cancer," and "cancer pain management."
  • Recent publications were prioritized, and articles were screened for relevance to prostate cancer and interest to urologists and pain specialists.

Main Results:

  • Prostate cancer cells exhibit elevated expression of cannabinoid receptors 1 and 2.
  • Cannabinoid receptor stimulation leads to reduced cell viability, increased apoptosis, and decreased androgen receptor expression and prostate-specific antigen (PSA) levels.

Conclusions:

  • Cannabinoids demonstrate potential anti-cancer effects in prostate cancer cells.
  • Clinical studies investigating cannabinoids for metastatic prostate cancer are warranted, considering their dual benefits for cancer treatment and pain management.
Keywords:
Androgen antagonistscannabinoidscannabisinvestigational therapiesprostatic neoplasms

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...